PDA Presents Largest Exhibit of Commercial Inspection Hardware at '15 Visual Inspection Forum

Oct 22, 2015, 12:21 ET from Parenteral Drug Association

BETHESDA, Md., Oct. 22, 2015 /PRNewswire-USNewswire/ -- In addition to the leading forum for visual inspection of parenteral products, the Parenteral Drug Association (PDA) is proud to offer the largest exhibition of commercial visual inspection hardware at the 2015 Visual Inspection Forum in Bethesda, Md., October 26-27.

Exhibitors showing off their latest inspection systems include forum sponsors Bosch Inspection Technology, Biothermal, and Kyoto Automation.  Attendees will receive the latest information in two full days of information-packed sessions, and then have a chance to see the latest visual inspection technologies that are critical to this important quality control function for sterile drug products.

"PDA has a long history of advancing the science of particulate visible inspection," said PDA President Richard Johnson. "This Forum is just one of the many ways our volunteers contribute to this field."

The Forum includes speakers representing industry and the U.S. FDA centers for drugs and biologics (CDER/CBER).  Eli Lilly, Merck, Genentech, and Sandoz are just a sampling of the companies sharing their knowledge and expertise at the event.

A sold out PDA Education course, "An Introduction to Visual Inspection," follows the forum.

About PDA – Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its 10,000 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.

Media Inquiries: Walt Morris, 301-656-5900, x. 148; morris@pda.org

Logo - http://photos.prnewswire.com/prnh/20130226/DC66667LOGO


SOURCE Parenteral Drug Association